Search company, investor...


Founded Year



Acquired | Acquired

Total Raised


About MedAvante

MedAvante is a global provider of technology-enabled signal detection solutions in clinical trials of treatments for central nervous system (CNS) disorders with more than a decade of experience improving scale-based diagnostic and outcome measurements. MedAvante standardizes rating scale administration and scoring through two primary services: the Virgil Investigative Study Platform for site-based assessments; and MedAvante Central Ratings for live assessments by highly calibrated remote central clinicians. Supported by operations teams in the US, Germany, Russia and Japan, MedAvante delivers services for clinical trials in more than 40 countries worldwide

Headquarters Location

100 American Metro Boulevard Suite 106

Hamilton, New Jersey, 08619,

United States


Missing: MedAvante's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: MedAvante's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing MedAvante

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MedAvante is included in 2 Expert Collections, including Clinical Trials Tech.


Clinical Trials Tech

364 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.


Biopharma Tech

326 items

MedAvante Patents

MedAvante has filed 1 patent.

The 3 most popular patent topics include:

  • Clinical research
  • Cloud storage
  • Computer memory
patents chart

Application Date

Grant Date


Related Topics




Cloud storage, Computer memory, Clinical research, Wireless networking, Data management


Application Date


Grant Date



Related Topics

Cloud storage, Computer memory, Clinical research, Wireless networking, Data management



Latest MedAvante News

WCG buys eCOA experts MedAvante and ProPhase

May 11, 2017

WIRB-Copernicus Group (WCG) continued an acquisition spree with purchases of electronic clinical outcome assessments (eCOA) specialists MedAvante and ProPhase. Both companies have a track record in providing technology solutions for central nervous system and behavioral health clinical data collection and analysis. The additions could make WCG a leader in that field. Hamilton, New Jersey-based MedAvante was co-founded by current CEO Paul Gilbert and president Amy Ellis in 2002. They recognized that pharmas’ constant failures in testing psychotropic drugs at that time were largely caused by subjective assessments, which can be prejudicial and biased. To solve that, the company created “Central Raters,” which uses phone or videoconference to remotely assess clinical outcome, and thus clears some of the irrelevant scoring variables and reduces the number of raters. After years of evolution and additions, the company’s services have culminated in Virgil, a cloud-based eSource platform that provides eCOA and data management for clinical trials in different therapeutic areas. Aiming at better signal detection of treatment efficacy, the eSource platform has conducted more than 687,000 assessments of 56,000 clinical trial subjects in 233,000 study visits, and its data have resulted in successful submissions to both the FDA and EMA, says the company. Similar to MedAvante, New York-based ProPhase also uses mobile devices to help select, surveillance and analyze behavioral endpoints or ePRO for clinical trials. Besides that, it also provides training for Raters, clinical research associates, as well as patients and caregivers. The company says it “specializes in the development of new outcome measures, calibration of real world outcomes, placebo response mitigation, and prediction of treatment adherence.” The two companies will be led by Jeffrey Litwin, M.D., as the CEO of the combined organization. “Combining the strengths of MedAvante and ProPhase with the expansive clinical research expertise and global reach of WCG will provide best-of-class expertise and services for those conducting clinical trials in the challenging fields of CNS and mental health,” said Litwin in a release . WCG, an industry leader in providing regulatory and ethical review services for clinical researches, has been in quite an acquisitive mood since 2016. In March 2016, it acquired Raleigh, NC-based Clintrax Global, which specializes in global clinical trial contract negotiation and site payments. It then signed a deal last June with karmadata for the latter’s proprietary clinical trial data management applications, as well as an exclusive license to use its big data on clinical trial investigators and trial sites. That same month, clinical trials information provider CenterWatch joined the WCG family. Just a week before this MedAvante-ProPhase deal, the Princeton, NJ-headquartered clinical trial supporter bought ThreeWire, a company focused on global patient recruitment, enrollment and retention. Read more on

MedAvante Frequently Asked Questions (FAQ)

  • When was MedAvante founded?

    MedAvante was founded in 2002.

  • Where is MedAvante's headquarters?

    MedAvante's headquarters is located at 100 American Metro Boulevard, Hamilton.

  • What is MedAvante's latest funding round?

    MedAvante's latest funding round is Acquired.

  • How much did MedAvante raise?

    MedAvante raised a total of $22.29M.

  • Who are the investors of MedAvante?

    Investors of MedAvante include WCG, EW Healthcare Partners, Goldman Sachs, Trevi Health Ventures, Princeton Ventures and 3 more.

  • Who are MedAvante's competitors?

    Competitors of MedAvante include ArisGlobal, YouMail, ThreeWire, Mytrus, Globalcare and 11 more.

Compare MedAvante to Competitors

Chiral Quest

Chiral Quest develops routes for intermediates and APIs and manages tech transfer to full-scale manufacturing. Chiral Quest aims to help its customers improve their operating efficiencies by: (1) shortening the time-line for production of complex APIs; (2) developing a scalable process that will provide increasing quantities as clinical trials advance; (3) managing an efficient and cost-effective supply chain for manufacture; (4) providing robust QC methods and a strong CMC package.

Norton Audits Logo
Norton Audits

Norton Audits aims to provide clinical trial monitoring, auditing, and training.

ArisGlobal Logo

Aris Global is a provider of Pharmacovigilance, Drug Safety Software & Monitoring, Clinical Trials Management, Medical Communications and Regulatory software solutions to the pharmaceutical and life sciences industries.

NCI Cancer Hospital

NCI Cancer Hospital is a private oncology centre in Malaysia that combines treatment and clinical research. NCI aims to provide a range of services from diagnosis, laboratory analysis, surgery, chemotherapy and radiotherapy. It operates to GCP and has conducted clinical trials for a number of pharmaceutical companies including Roche, BMS and AstraZeneca.


C-TASC (Clinical Trials & Surveys Corporation) was founded in 1989 to coordinate, manage, and provide statistical support for clinical trials and observational studies. C-TASC is a 100% employee owned business which completed a management-led buyout in 2004 from its parent company. C-TASC conducts clinical trials, cohort studies, cross-sectional studies and case-control studies.

Nuvita Logo

Nuvita is a corporate wellness solution. Nuvita is designed to improve employee health and reduce costs.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.